No retraction, correction or concern found when last checked on Nov 2, 2026.

Triacylglycerol synthesis enhances macrophage inflammatory function

Angela Castoldi, Lauar B. Monteiro, Nikki van Teijlingen Bakker and 12 more (opens in a new tab)

Nature Communications · 2020 · CC BY

doi:10.1038/s41467-020-17881-3 (opens in a new tab)

Abstract

Foamy macrophages, which have prominent lipid droplets (LDs), are found in a variety of disease states. Toll-like receptor agonists drive triacylglycerol (TG)-rich LD development in macrophages. Here we explore the basis and significance of this process. Our findings indicate that LD development is the result of metabolic commitment to TG synthesis on a background of decreased fatty acid oxidation. TG synthesis is essential for optimal inflammatory macrophage activation as its inhibition, which prevents LD development, has marked effects on the production of inflammatory mediators, including IL-1β, IL-6 and PGE2, and on phagocytic capacity. The failure of inflammatory macrophages to make PGE2 when TG-synthesis is inhibited is critical for this phenotype, as addition of exogenous PGE2 is able to reverse the anti-inflammatory effects of TG synthesis inhibition. These findings place LDs in a position of central importance in inflammatory macrophage activation.

References 51

1.
Guerrini V, Gennaro ML. Foam cells: one size doesn’t fit all. Trends Immunol. 2019.
Not in our library10.1016/j.it.2019.10.002 (opens in a new tab)
2.
Thiam AR, Farese RV, Walther TC. The biophysics and cell biology of lipid droplets. Nat. Rev. Mol. Cell Biol. 2013;14:775-786.
Not in our library10.1038/nrm3699 (opens in a new tab)
3.
Huang YL, et al. Toll-like receptor agonists promote prolonged triglyceride storage in macrophages. J. Biol. Chem. 2014;289:3001-3012.
Not in our library10.1074/jbc.m113.524587 (opens in a new tab)
4.
Huang SC, et al. Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat. Immunol. 2014;15:846-855.
Not in our library10.1038/ni.2956 (opens in a new tab)
5.
Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011;117:3720-3732.
Not in our library10.1182/blood-2010-07-273417 (opens in a new tab)
6.
O’Neill LA, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J. Exp. Med. 2016;213:15-23.
Not in our library10.1084/jem.20151570 (opens in a new tab)
7.
Jha AK, et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity. 2015;42:419-430.
Not in our library10.1016/j.immuni.2015.02.005 (opens in a new tab)
8.
Dennis EA, et al. A mouse macrophage lipidome. J. Biol. Chem. 2010;285:39976-39985.
Not in our library10.1074/jbc.m110.182915 (opens in a new tab)
9.
Funk JL, Feingold KR, Moser AH, Grunfeld C. Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation. Atherosclerosis. 1993;98:67-82.
Not in our library10.1016/0021-9150(93)90224-i (opens in a new tab)
10.
Yen CL, Stone SJ, Koliwad S, Harris C, Farese RV. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J. Lipid Res. 2008;49:2283-2301.
Not in our library10.1194/jlr.r800018-jlr200 (opens in a new tab)
11.
Henne, W. M., Reese, M. L. & Goodman, J. M. The assembly of lipid droplets and their roles in challenged cells. EMBO J. 37, 10.15252/embj.201898947 (2018).
Not in our library10.15252/embj.201898947 (opens in a new tab)
12.
Chitraju C, et al. Triglyceride synthesis by DGAT1 protects adipocytes from lipid-induced ER stress during lipolysis. Cell Metab. 2017;26:407-418.e403.
Not in our library10.1016/j.cmet.2017.07.012 (opens in a new tab)
13.
Piccolis M, et al. Probing the global cellular responses to lipotoxicity caused by saturated fatty acids. Mol. Cell. 2019;74:32-44.e38.
Not in our library10.1016/j.molcel.2019.01.036 (opens in a new tab)
14.
Bandeira-Melo C, Weller PF, Bozza PT. Identifying intracellular sites of eicosanoid lipid mediator synthesis with EicosaCell assays. Methods Mol. Biol. 2011;717:277-289.
Not in our library10.1007/978-1-61779-024-9_16 (opens in a new tab)
15.
Melo RC, Weller PF. Lipid droplets in leukocytes: organelles linked to inflammatory responses. Exp. Cell Res. 2016;340:193-197.
Not in our library10.1016/j.yexcr.2015.10.028 (opens in a new tab)
16.
Li AC, Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nat. Med. 2002;8:1235-1242.
Not in our library10.1038/nm1102-1235 (opens in a new tab)
17.
Childs BG, et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science. 2016;354:472-477.
Not in our library10.1126/science.aaf6659 (opens in a new tab)
18.
Kim K, et al. Transcriptome analysis reveals nonfoamy rather than foamy plaque macrophages are proinflammatory in atherosclerotic murine models. Circ. Res. 2018;123:1127-1142.
Not in our library10.1161/circresaha.118.312804 (opens in a new tab)
19.
Cameron AM, et al. Inflammatory macrophage dependence on NAD. Nat. Immunol. 2019;20:420-432.
Not in our library10.1038/s41590-019-0336-y (opens in a new tab)
20.
Cao J, et al. Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases. J. Biol. Chem. 2011;286:41838-41851.
Not in our library10.1074/jbc.m111.245456 (opens in a new tab)
21.
Jaisinghani N, et al. Necrosis driven triglyceride synthesis primes macrophages for inflammation during. Front. Immunol. 2018;9:1490.
Not in our library10.3389/fimmu.2018.01490 (opens in a new tab)
22.
Freigang S, et al. Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis. Nat. Immunol. 2013;14:1045-1053.
Not in our library10.1038/ni.2704 (opens in a new tab)
23.
Chandak PG, et al. Efficient phagocytosis requires triacylglycerol hydrolysis by adipose triglyceride lipase. J. Biol. Chem. 2010;285:20192-20201.
Not in our library10.1074/jbc.m110.107854 (opens in a new tab)
24.
Cogliati S, et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell. 2013;155:160-171.
Not in our library10.1016/j.cell.2013.08.032 (opens in a new tab)
25.
Buck MD, et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell. 2016;166:63-76.
Not in our library10.1016/j.cell.2016.05.035 (opens in a new tab)
26.
Liepinsh E, et al. Long-chain acylcarnitines determine ischaemia/reperfusion-induced damage in heart mitochondria. Biochem. J. 2016;473:1191-1202.
Not in our library10.1042/bcj20160164 (opens in a new tab)
27.
Everts B, et al. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation. Nat. Immunol. 2014;15:323-332.
Not in our library10.1038/ni.2833 (opens in a new tab)
28.
Zasłona Z, et al. The induction of Pro-IL-1β by lipopolysaccharide requires endogenous prostaglandin E. J. Immunol. 2017;198:3558-3564.
Not in our library10.4049/jimmunol.1602072 (opens in a new tab)
29.
O’Neill LAJ, Artyomov MN. Itaconate: the poster child of metabolic reprogramming in macrophage function. Nat. Rev. Immunol. 2019;19:273-281.
Not in our library10.1038/s41577-019-0128-5 (opens in a new tab)
30.
A Role for the Krebs Cycle Intermediate Citrate in Metabolic Reprogramming in Innate Immunity and Inflammation · 2018
No notice
31.
Fuchs, A. L. et al. Quantitative. Metabolites9, 10.3390/metabo9110248 (2019).
Not in our library
32.
Nguyen TB, et al. DGAT1-dependent lipid droplet biogenesis protects mitochondrial function during starvation-induced autophagy. Dev. Cell. 2017;42:9-21.e25.
Not in our library10.1016/j.devcel.2017.06.003 (opens in a new tab)
33.
Lipid droplet formation in Mycobacterium tuberculosis infected macrophages requires IFN-γ/HIF-1α signaling and supports host defense · 2018
No notice
34.
Triglycerides Promote Lipid Homeostasis during Hypoxic Stress by Balancing Fatty Acid Saturation · 2018
No notice
35.
Violante S, et al. Carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines. FASEB J. 2013;27:2039-2044.
Not in our library10.1096/fj.12-216689 (opens in a new tab)
36.
Rutkowsky JM, et al. Acylcarnitines activate proinflammatory signaling pathways. Am. J. Physiol. Endocrinol. Metab. 2014;306:E1378-E1387.
Not in our library10.1152/ajpendo.00656.2013 (opens in a new tab)
37.
Nomura M, et al. Macrophage fatty acid oxidation inhibits atherosclerosis progression. J. Mol. Cell Cardiol. 2019;127:270-276.
Not in our library10.1016/j.yjmcc.2019.01.003 (opens in a new tab)
38.
Malandrino MI, et al. Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation. Am. J. Physiol. Endocrinol. Metab. 2015;308:E756-E769.
Not in our library10.1152/ajpendo.00362.2014 (opens in a new tab)
39.
Dinarello CA. A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur. J. Immunol. 2011;41:1203-1217.
Not in our library10.1002/eji.201141550 (opens in a new tab)
40.
Divangahi M, et al. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 2009;10:899-906.
Not in our library10.1038/ni.1758 (opens in a new tab)
41.
Chen M, et al. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J. Exp. Med. 2008;205:2791-2801.
Not in our library10.1084/jem.20080767 (opens in a new tab)
42.
Ridker PM, et al. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet. 2017;390:1833-1842.
Not in our library10.1016/s0140-6736(17)32247-x (opens in a new tab)
43.
Ridker PM, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 2017;377:1119-1131.
Not in our library10.1056/nejmoa1707914 (opens in a new tab)
44.
Lachmann HJ, et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N. Engl. J. Med. 2009;360:2416-2425.
Not in our library10.1056/nejmoa0810787 (opens in a new tab)
45.
Leow MK. PTEN haploinsufficiency, obesity, and insulin sensitivity. N. Engl. J. Med. 2012;367:2450-2451.
Not in our library10.1056/nejmc1212931 (opens in a new tab)
46.
Yagami T, Koma H, Yamamoto Y. Pathophysiological roles of cyclooxygenases and prostaglandins in the central nervous system. Mol. Neurobiol. 2016;53:4754-4771.
Not in our library10.1007/s12035-015-9355-3 (opens in a new tab)
47.
Venegas C, Heneka MT. Danger-associated molecular patterns in Alzheimer’s disease. J. Leukoc. Biol. 2017;101:87-98.
Not in our library10.1189/jlb.3mr0416-204r (opens in a new tab)
48.
Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics*s⃞ · 2008
Not checked
49.
Buescher JM, et al. A roadmap for interpreting (13)C metabolite labeling patterns from cells. Curr. Opin. Biotechnol. 2015;34:189-201.
Not in our library10.1016/j.copbio.2015.02.003 (opens in a new tab)
50.
snakePipes: facilitating flexible, scalable and integrative epigenomic analysis · 2019
No notice
51.
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 · 2014
No notice

Cited by papers we hold 4

Questions about this paper

We email you if it is retracted, withdrawn, corrected or flagged.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.